SLC22A18: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m Citations: [Pu168] added: doi. Tweaked: pmc. You can use this bot yourself! Report bugs here.
m [Pu372]Add: author2, author3, display-authors, last4, first4, last5, first5, last6, first6, last7, first7, last8, first8, last9, first9. Tweak: author, title. Combined duplicate references.
Line 5: Line 5:
{{PBB_Summary
{{PBB_Summary
| section_title =
| section_title =
| summary_text = This gene is one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region as well as the transport of chloroquine- and quinidine-related compounds in the kidney. Two alternative transcripts encoding the same isoform have been described.<ref name="entrez">{{cite web | title = Entrez Gene: SLC22A18 solute carrier family 22 (organic cation transporter), member 18| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5002| accessdate = }}</ref>
| summary_text = This gene is one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region as well as the transport of chloroquine- and quinidine-related compounds in the kidney. Two alternative transcripts encoding the same isoform have been described.<ref name="entrez" />
}}
}}


Line 19: Line 19:
| citations =
| citations =
*{{cite journal | author=Akiyama S |title=[Mechanisms of drug resistance and reversal of the resistance] |journal=Hum. Cell |volume=14 |issue= 4 |pages= 257–60 |year= 2002 |pmid= 11925925 |doi= }}
*{{cite journal | author=Akiyama S |title=[Mechanisms of drug resistance and reversal of the resistance] |journal=Hum. Cell |volume=14 |issue= 4 |pages= 257–60 |year= 2002 |pmid= 11925925 |doi= }}
*{{cite journal | author=Cooper PR, Smilinich NJ, Day CD, ''et al.'' |title=Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domain. |journal=Genomics |volume=49 |issue= 1 |pages= 38–51 |year= 1998 |pmid= 9570947 |doi= 10.1006/geno.1998.5221 }}
*{{cite journal | author=Cooper PR |title=Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domain |journal=Genomics |volume=49 |issue= 1 |pages= 38–51 |year= 1998 |pmid= 9570947 |doi= 10.1006/geno.1998.5221 | author2=Smilinich NJ | author3=Day CD | display-authors=3 | last4=Nowak | first4=NJ | last5=Reid | first5=LH | last6=Pearsall | first6=RS | last7=Reece | first7=M | last8=Prawitt | first8=D | last9=Landers | first9=J }}
*{{cite journal | author=Reece M, Prawitt D, Landers J, ''et al.'' |title=Functional characterization of ORCTL2--an organic cation transporter expressed in the renal proximal tubules. |journal=FEBS Lett. |volume=433 |issue= 3 |pages= 245–50 |year= 1998 |pmid= 9744804 |doi=10.1016/S0014-5793(98)00907-7 }}
*{{cite journal | author=Reece M |title=Functional characterization of ORCTL2--an organic cation transporter expressed in the renal proximal tubules |journal=FEBS Lett. |volume=433 |issue= 3 |pages= 245–50 |year= 1998 |pmid= 9744804 |doi=10.1016/S0014-5793(98)00907-7 | author2=Prawitt D | author3=Landers J | display-authors=3 | last4=Kast | first4=C | last5=Gros | first5=P | last6=Housman | first6=D | last7=Zabel | first7=BU | last8=Pelletier | first8=J }}
*{{cite journal | author=Lee MP, Reeves C, Schmitt A, ''et al.'' |title=Somatic mutation of TSSC5, a novel imprinted gene from human chromosome 11p15.5. |journal=Cancer Res. |volume=58 |issue= 18 |pages= 4155–9 |year= 1998 |pmid= 9751628 |doi= }}
*{{cite journal | author=Lee MP |title=Somatic mutation of TSSC5, a novel imprinted gene from human chromosome 11p15.5 |journal=Cancer Res. |volume=58 |issue= 18 |pages= 4155–9 |year= 1998 |pmid= 9751628 |doi= | author2=Reeves C | author3=Schmitt A | display-authors=3 | last4=Su | first4=K | last5=Connors | first5=TD | last6=Hu | first6=RJ | last7=Brandenburg | first7=S | last8=Lee | first8=MJ | last9=Miller | first9=G }}
*{{cite journal | author=Morisaki H, Hatada I, Morisaki T, Mukai T |title=A novel gene, ITM, located between p57KIP2 and IPL, is imprinted in mice. |journal=DNA Res. |volume=5 |issue= 4 |pages= 235–40 |year= 1999 |pmid= 9802569 |doi=10.1093/dnares/5.4.235 }}
*{{cite journal | author=Morisaki H, Hatada I, Morisaki T, Mukai T |title=A novel gene, ITM, located between p57KIP2 and IPL, is imprinted in mice |journal=DNA Res. |volume=5 |issue= 4 |pages= 235–40 |year= 1999 |pmid= 9802569 |doi=10.1093/dnares/5.4.235 }}
*{{cite journal | author=Onyango P, Miller W, Lehoczky J, ''et al.'' |title=Sequence and comparative analysis of the mouse 1-megabase region orthologous to the human 11p15 imprinted domain. |journal=Genome Res. |volume=10 |issue= 11 |pages= 1697–710 |year= 2001 |pmid= 11076855 |doi=10.1101/gr.161800 }}
*{{cite journal | author=Onyango P |title=Sequence and comparative analysis of the mouse 1-megabase region orthologous to the human 11p15 imprinted domain |journal=Genome Res. |volume=10 |issue= 11 |pages= 1697–710 |year= 2001 |pmid= 11076855 |doi=10.1101/gr.161800 | author2=Miller W | author3=Lehoczky J | display-authors=3 | last4=Leung | first4=CT | last5=Birren | first5=B | last6=Wheelan | first6=S | last7=Dewar | first7=K | last8=Feinberg | first8=AP }}
*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 }}
*{{cite journal | author=Strausberg RL |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 | author2=Feingold EA | author3=Grouse LH | display-authors=3 | last4=Derge | first4=JG | last5=Klausner | first5=RD | last6=Collins | first6=FS | last7=Wagner | first7=L | last8=Shenmen | first8=CM | last9=Schuler | first9=GD }}
*{{cite journal | author=Gerhard DS, Wagner L, Feingold EA, ''et al.'' |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 }}
*{{cite journal | author=Gerhard DS |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC) |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 | author2=Wagner L | author3=Feingold EA | display-authors=3 | last4=Shenmen | first4=CM | last5=Grouse | first5=LH | last6=Schuler | first6=G | last7=Klein | first7=SL | last8=Old | first8=S | last9=Rasooly | first9=R }}
*{{cite journal | author=Yamada HY, Gorbsky GJ |title=Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105. |journal=Oncogene |volume=25 |issue= 9 |pages= 1330–9 |year= 2006 |pmid= 16314844 |doi= 10.1038/sj.onc.1209167 | pmc=2713668 }}
*{{cite journal | author=Yamada HY, Gorbsky GJ |title=Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105 |journal=Oncogene |volume=25 |issue= 9 |pages= 1330–9 |year= 2006 |pmid= 16314844 |doi= 10.1038/sj.onc.1209167 | pmc=2713668 }}
*{{cite journal | author=Gallagher E, Mc Goldrick A, Chung WY, ''et al.'' |title=Gain of imprinting of SLC22A18 sense and antisense transcripts in human breast cancer. |journal=Genomics |volume=88 |issue= 1 |pages= 12–7 |year= 2006 |pmid= 16624517 |doi= 10.1016/j.ygeno.2006.02.004 }}
*{{cite journal | author=Gallagher E |title=Gain of imprinting of SLC22A18 sense and antisense transcripts in human breast cancer |journal=Genomics |volume=88 |issue= 1 |pages= 12–7 |year= 2006 |pmid= 16624517 |doi= 10.1016/j.ygeno.2006.02.004 | author2=Mc Goldrick A | author3=Chung WY | display-authors=3 | last4=Mc Cormack | first4=O. | last5=Harrison | first5=M. | last6=Kerin | first6=M. | last7=Dervan | first7=P.A. | last8=Mc Cann | first8=A. }}
}}
}}
{{refend}}
{{refend}}

Revision as of 06:14, 19 June 2011

Template:PBB Solute carrier family 22 member 18 is a protein that in humans is encoded by the SLC22A18 gene.[1][2][3]

Template:PBB Summary

See also

References

  1. ^ Dao D, Frank D, Qian N, O'Keefe D, Vosatka RJ, Walsh CP, Tycko B (1998). "IMPT1, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes". Hum Mol Genet. 7 (4): 597–608. doi:10.1093/hmg/7.4.597. PMID 9499412. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  2. ^ Schwienbacher C, Sabbioni S, Campi M, Veronese A, Bernardi G, Menegatti A, Hatada I, Mukai T, Ohashi H, Barbanti-Brodano G, Croce CM, Negrini M (1998). "Transcriptional map of 170-kb region at chromosome 11p15.5: identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples". Proc Natl Acad Sci U S A. 95 (7): 3873–8. doi:10.1073/pnas.95.7.3873. PMC 19930. PMID 9520460. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  3. ^ "Entrez Gene: SLC22A18 solute carrier family 22 (organic cation transporter), member 18".

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

Template:PBB Controls